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INTRODUCTION 
The right (RV) and left (LV) ventricles differ markedly in shape and 
myocardial contractile element density. Despite these differences, the 
synchronous electrical excitation and mechanical contraction of both the 
ventricles and the ventricular interdependence maintains the biventricular 
function in balance 
13
. This is known as ventricular synchrony. Certain disease 
states like ischemic heart disease (IHD), acute pulmonary embolism, conduction 
disorders like left bundle branch block (LBBB), preexcitation, and ventricular 
pacing alters this balance resulting in ventricular dyssynchrony. 
RV apical permanent pacemaker implantation (PPI) with ventricular 
inhibited pacing (VVI) mode is known to produce ventricular dyssynchrony by 
abnormal electrical and mechanical activation of the ventricles. Long-term RV 
apical pacing is also associated with detrimental effects on cardiac structure and 
left ventricular (LV) function
15
. Echocardiographic evaluation of LV and RV 
systolic function by measuring mitral annular plane systolic excursion 
(MAPSE) 
8
 and tricuspid annular plane systolic excursion (TAPSE)
9
 and their 
ratio (MAPSE/TAPSE ratio)
12
 has been shown to correlate with ventricular 
synchrony in normal healthy individuals. M-mode echocardiographic evaluation 
of MAPSE, TAPSE, and their ratio can provide information regarding the 
degree of ventricular dyssynchrony in patients with VVI pacing. 
  
       AIMS AND OBJECTIVES 
1. To assess the systolic function of left and right ventricle by mitral 
and tricuspid annular plane systolic excursions in patients with VVI pacing. 
2. To analyse the interventricular systolic relationship using    
MAPSE/TAPSE ratio in patients with VVI pacemaker implantation. 
 
 
 
 
 
 
 
  
REVIEW OF LITERATURE 
Conduction System of the Heart 
Automaticity   
The inherent ability of the electrically active cells of the heart to 
spontaneously depolarize resulting in electrical activation of the heart is known 
as automaticity. The sinoatrial (SA) node is the dominant pacemaker of the 
heart, consisting of a collection of pacemaker cells, located in the upper portion 
of the right atrium (RA), close to the insertion of the superior vena cava (SVC). 
The SA nodal discharge typically produces a heart rate of around 70 beats per 
minute (bpm) in a healthy person. The SA nodal discharge rate responds to 
various physiological events and increases heart rate during exercise, fever and 
emotional stress, and decreases heart rate during rest or increased vagal tone. 
These changes are mediated by the changes in the neural balance maintained 
between the sympathetic and the vagal system. 
The intrinsic discharge rate of the atrial myocardial cells is usually 
around 40-50 bpm and hence are suppressed by the higher rate of discharge by 
the SA node. But occasionally, atria may show increased automaticity leading 
to an atrial premature contraction (APC) or an atrial tachycardia. In addition, 
slowing of the sinus heart rate can allow the atrioventricular (AV) node to 
discharge and pace the heart with a junctional rhythm with a stable rate of about 
40 or 50 bpm
31
. Myocardial ischemia, myocarditis, digitalis toxicity and cardiac 
surgery can lead to a more rapid junctional rhythm called non-paroxysmal 
junctional tachycardia. 
The ventricle is at the bottom of the hierarchy. In patients with complete 
heart block (CHB), the sinus nodal discharge does not reach the ventricle in a 
one-to-one ratio due to the block. So, the ventricle starts discharging producing 
a ventricular escape rhythm. This rhythm, in the presence of complete heart 
block, is ominous and usually occurs at a very slow rate of around 20-30 bpm. 
This extremely slow rhythm is potentially lethal as it results in prolongation of 
the QT interval which may precipitate polymorphic ventricular tachycardia 
(VT). 
Sinus Node and Atrium: 
The sinus node is located subepithelially in the high RA near the junction 
of SVC. SA nodal cells undergo spontaneous depolarization at a rate of 
approximately 60-100 bpm. The electrical discharge from the SA node is not 
routinely recorded with electrophysiologic studies and standard intracardiac 
catheters. The sinus node is highly responsive to a variety of physiologic 
stimuli, adjusting the discharge rate by going slow or fast, as appropriate. This 
physiological response by the SA node can be reproduced to some extent by 
rate-adaptive pacemakers.  
The atrium is the chamber that conducts electrical discharge from the 
sinus node down to the AV node. Cardiac myocytes are electrically coupled 
with one another through the gap junctions. These gap junctions allow the 
transmission of electrical impulses to travel through the atrial myocardium 
towards the AV node. The gap junctions are mainly composed of  intercellular 
adhesion molecules called connexions. This atrial depolarization forms a P 
wave on the electrocardiogram. The total time taken for the transmission of 
impulses through the atria to the AV node is approximately 100 msec. The atria 
also function as conduits for the returning venous blood that is pushed into their 
respective left (LV) and right (RV) ventricles. The atrial contribution to 
ventricular filling accounts for as much as 30% of the total stroke volume. This 
in turn results in an improvement in cardiac output through the Frank-Starling 
mechanism. Maintaining atrioventricular synchrony is an important goal with 
dual-chamber pacemakers.  
AV Node: 
The atria are separated from the ventricles by the two atrioventricular 
valves and their supporting fibrous tissue. This fibrous skeleton essentially acts 
as an insulator preventing the simultaneous electrical activation of the upper and 
lower chambers. The only normal electrical pathway between the atria and the 
ventricles is the through the AV node which is situated subepithelially in the 
RA close to the coronary sinus.  
The electrical impulses from the SA node travelling down towards the 
ventricles are slowed down by the AV node. This  atrioventricular delay is 
approximately 80 msec. This brief delay in the conduction of the depolarization 
wave from atria to the ventricles, also known as “electrical modulation”, has 
great functional significance because this delay allows the blood to be emptied 
near completely from the atria into the ventricles. This atrial contraction 
augmented emptying of blood accounts for an additional contribution to the 
end-diastolic ventricular volume by approximately 30%, thus allowing for more 
efficient cardiac output.  
The AV node is responsive to both vagal and sympathetic input. 
Heightened vagal activity in trained athletes can result is marked slowing of the 
heart rate, producing asymptomatic episodes of intermittent block in the AV 
node. The delayed AV nodal conduction may further get impaired in certain 
disease states like degenerative nodal calcification and myocardial ischemia, 
resulting in atrioventricular conduction blocks, including complete heart block, 
necessitating ventricular pacemaker. The AV node also has the property of 
retrograde conduction, allowing ventriculo-atrial (VA) conduction during 
ventricular tachycardias and ventricular pacing. 
His-Purkinje System: 
The electrical activity from the SA node that has been briefly slowed in 
the AV node enters the His-Purkine system, which constitutes the first portion 
of the specialized conduction system of the heart having rapid conducting 
properties. The Purkinje fibers are very long fibers with abundant 
concentrations of gap junction. This contributes to the very high conduction 
speeds of 3-4 m/sec in the His-Purkinje as opposed to the relatively slow 
conduction (0.3-1 m/sec) speed of the working myocardium.  
The initial portion of this part of the conduction system is the bundle of 
His and is a fairly thick bundle of cells. The His-Purkinje system is essentially a 
trifascicular network. The bundle of His almost immediately splits into the two 
components of the Purkinje system: the right and left bundle branches. The left 
bundle is further divided into the left anterosuperior and left posteroinferior 
fascicles. This can be explained teleologically as a rapidly conducting electrical 
system that spreads through the LV and RV myocardium to allow almost 
simultaneous, synchronized, contraction of the ventricles. The recent advance in 
cardiac resynchronization therapy (CRT) for congestive heart failure (CHF) 
represents an effort to reproduce this effect. Disruption of these bundles is quite 
common and results in left bundle branch block (LBBB) and right bundle 
branch block (RBBB) which are routinely diagnosed on surface 
electrocardiogram (ECG). The clinical significance of these blocks is dependent 
on the clinical scenario and can range from completely benign to pathological. 
Ventricular myocardium: 
The ventricular myocardium is electrically isolated from the His-Purkinje 
system in all the regions except at the Purkinje-myocardial junction. The 
regions of the ventricular myocardium that are activated earliest are the RV 
anterolateral wall and the LV inferolateral wall. This is followed by early apical 
activation, and further spread of the electrical impulses occur in a apex-to-base 
sequence. Simultaneously, there also occurs endocardial-to-epicardial spread of 
excitation front. The last parts of the RV to be activated are the AV sulcus and 
the pulmonary conus. Similarly, the last part of the LV to be activated is the 
posterobasal area. The time interval between the impulses arriving at the His 
bundle and the first ventricular activation is around 20 msec. The complete 
ventricular activation is completed in around 60-80 msec. 
Mechanical activation under physiological states: 
The electrical activation of the heart results in mechanical contraction of 
the myocardial fibers, mediated by the process of “electro-mechanical 
coupling”. The spontaneous depolarization of the SA nodal cells is followed by 
spread of the depolarization wave along the entire cardiac conduction system. 
This results in the opening up of the calcium (Ca2+) channels in the surface of 
the myocardial cells, resulting in increased calcium entry into the cells. This 
calcium further mediates the release of more calcium from the sarcoplasmic 
reticulum (SR) through calcium-induced calcium release (CICR) channels, 
thereby increasing the intracytoplasmic calcium concentrations upto ten times. 
Calcium then binds with the troponon-C protein causing activation of the 
troponin complex. This is followed by an increase in the actin-myosin 
interaction which produces myocardial fiber contraction. 
Ventricular contraction is followed by relaxation of the myocardial fibers. 
At the end of myocardial contraction, with the depletion of  adenosine 
triphosphate (ATP), the calcium ions dissociate themselves from the troponin 
complex and are released into the cytoplasm. This released calcium is removed 
from the cytoplasm by two major systems: the reuptake of calcium into the SR 
by the sarcoplasmic reticulum Ca2+-ATPase (SERCA) and the efflux of 
calcium outside of the cells through the sarcolemmal sodium-calcium exchanger 
(NCX) pump. The SERCA mechanism is the dominant mechanism accounting 
for the removal of upto 80% of the cytoplasmic calcium under physiological 
states and the NCX accounts for upto 10-15% of total calcium efflux. This 
finally results in myocardial relaxation.  
Interventricular relationship and Ventricular dyssynchrony 
Synchronous Ventricular Contraction: 
 The left ventricle (LV) and the right ventricle (RV) differ markedly 
in shape, thickness and density of the myocardial contractile elements. In spite 
of these differences, both the ventricles function in a smooth and coordinated 
manner maintaining normal biventricular function. This is mediated by the 
synchronous excitation of the cardiac conduction system as well as the 
contraction of the myocardial fibers. The electrical activation of the heart begins 
in the sinoatrial (SA) node and spreads through the atrioventricular (AV) node 
to the His bundle, bundle braches and Purkinje fibers finally resulting in the 
activation of the myocardial fibers through the Purkinje-myocardial coupling. 
The His-Purkinje system is extremely important in maintaining the synchronous 
activity of the myocardium, because of its widespread distribution in the 
ventricles and unique propagation properties. The result of this is a high degree 
of coordinated mechanical contraction between remote regions of the 
myocardium. 
Ventricular dyssynchrony: 
Ventricular dyssynchrony can be defined as an abnormality of the 
normal, organized electromechanical coupling of the ventricles and this 
disturbance is the consequence of an intra or interventricular conduction delay
1
. 
Ventricular dyssynchrony results in the early electrical activation of the RV 
before LV activation. Also, RV depolarization and mechanical contraction 
occurs earlier followed by LV depolarization and mechanical contraction. This 
altered ventricular activation sequence has the following hemodynamic effects : 
(i) Reduction in the LV contractility 
(ii) Decreased LV diastolic filling times with reduced preload 
(iii) Mitral regurgitation due to delayed activation of the posteromedial 
papillary muscle 
(iv) Paradoxical septal motion resulting in reduced contribution of the 
interventricular septum (IVS) to LV stroke volume 
These hemodynamic effects are particularly troublesome in patients with 
heart failure resulting in progressively downhill course with increased morbidity 
and mortality. 
 Electrical dyssynchrony is defined by an abnormally widened 
surface QRS duration exceeding 120 msec in any electrocardiographic limb 
lead. Mechanical dyssynchrony refers to presence of abnormal activation 
timing within or between the ventricles as evidenced by echocardiography
2
.  
Types of Ventricular Dyssynchrony: 
Left ventricular dyssynchrony occurs in the settings of impaired 
ventricular interaction and is of 3 types: 
1. Atrioventricular dyssynchrony resulting from atrial and ventricular 
activation occurring out of phase. 
2. Interventricular dyssynchrony resulting from altered activation timings 
between the ventricles. 
3. Intraventricular dyssynchrony resulting from differential activation 
among the various segments of the LV itself. 
Echocardiographic assessment of Ventricular dyssynchrony: 
Atrioventricular dyssynchrony is assessed echocardiographically by 
measuring the LV diastolic filling time (DFT) using pulsed wave doppler 
(PWD) in the apical 4-chamber view. DFT is measured from the beginning of 
the E- wave to the end of the A wave in the mitral inflow velocity recordings. 
Atrioventricular dyssynchrony is present if the DFT is < 40% of the cardiac 
cycle. 
Interventricular dyssynchrony is currently best assessed by measuring the 
interventricular mechanical delay (IVMD). IVMD is defined as the time 
difference between left and right ventricular pre-ejection intervals measured by 
PWD. The pre-ejection intervals are measured from the beginning of the QRS 
complex to the beginning of the pulmonary (Q-PV) or aortic ejection (Q-AV). 
Normal IVMD is < 40 milliseconds (ms). Interventricular dyssynchrony is 
present if IVMD is > 40 ms
3
. Tissue doppler imaging (TDI) is also used in the 
assessment where any delay between the onset of systolic motion between the 
basal RV free wall and the most delayed LV segment is measured. A delay > 56 
ms is considered abnormal. 
Intraventricular dyssynchrony is assessed by various methods, but the 
two most widely accepted methods are: 
(i) M-mode echocardiographic measurement of septal-to-posterior 
wall motion delay (SPWMD). SPWMD is obtained in the parasternal short axis 
view at the papillary muscle level by measuring the delay between the peak 
systolic excursion of the anterior (septal) and the posterior walls. SPWMD 
value of 130 ms or more is considered abnormal 
4
. 
(ii) Color-coded TDI showing a delay  ≥ 65ms between any two walls 
( usually between septal and lateral walls) from QRS onset to peak contraction, 
assessed in either the apical 3-, 4-, or 5-chamber view. The color-coded TDI 
method is the most preferred method for assessing intraventricular 
dyssynchrony and patient outcomes
5
. 
Mitral Annular Plane Systolic Excursion (MAPSE) 
Mitral annular ring:  
The harmony of the mitral valve opening and closure, and LV filling and 
emptying is maintained by the anatomical integrity of the “left atrial- mitral 
valve-left ventricular complex”. An essential component of this complex is the 
mitral annular ring providing support to the mitral valve. During LV contraction 
and relaxation, this mitral annular ring also undergoes a complex motion 
composed of three components: motion in long-axis (base-to-apex), constricting 
motion in a sphincter-like fashion, and rotation. The base-to-apex motion of the 
mitral annular ring was first described in details by Zaky et al
6
. 
LV systolic function by echocardiography: 
Left ventricular systolic function is traditionally assessed by 
echocardiography using a variety of parameters including LV ejection fraction 
(LVEF), using either Teichholz method or modified Simpson method, LV 
fractional shortening (LVFS), LV fractional area change (LV FAC), LV outflow 
tract acceleration time, and mitral dP/dt. Among these, the most widely 
accepted and used parameter is the LVEF. Left ventricular ejection fraction is a 
measure of the LV systolic function along both its circular and longitudinal axis 
and reduced ejection fraction has been correlated with prognosis, both short 
term and long term, in various heart diseases. 
Longitudinal motion of left ventricle: 
The systolic contraction and diastolic relaxation of the LV myocardium is 
mediated mainly by two groups of muscle fibers: longitudinal fibers present in 
the subendocardial layer, subepicardial layers as well as in papillary muscles, 
and circular muscle fibers present predominantly in the subepicardial layer. 
During myocardial contraction, the longitudinal fibers begin to contract earlier 
than the circular fibers. 
 In disease states with altered contractility, both the longitudinal and 
rotational motion of the myocardium is affected. But, it has been shown by 
Bolognesi et al that in diseased states like myocardial ischemia or infarction, the 
longitudinal motion is affected first
7
. Thus, echocardiographic evaluation of 
longitudinal motion of myocardium may help in diagnosing cardiac dysfunction 
at an early stage of disease process itself. 
Mitral annular plane systolic excursion: 
MAPSE  is an echocardiographic parameter useful in assessing the 
longitudinal function of the left ventricle. It is measured by M-mode 
echocardiography by placing the patient in the left lateral position and obtaining 
an apical-4-chamber view. The M-mode beam is placed along the lateral 
annulus of the mitral valve and the maximal excursion of the mitral annular 
plane in systole is measured. The annular plane is identified in M-mode 
recording as the first continuous line seen immediately below the LV cavity. 
The normal range for MAPSE is 12 +/- 2 mm (men: >13 mm and women 
>11 mm).  Values less than 10 mm is considered abnormal and correlates with 
LVEF and cardiac dysfunction. Reduction in the MAPSE has been 
demonstrated in many disease states like ischemic heart disease, acute 
myocardial infarction, severe aortic stenosis, cardiomyopathies. The systolic LV 
function as assessed by MAPSE  has also been shown to have high correlation 
with brain natriuretic peptide (BNP) levels in patients with heart failure
8
. 
Tricuspid Annular Plane Systolic Excursion (TAPSE) 
Tricuspid annular ring and its motion: 
Similar to the left side of the heart, the coordinated functioning of the 
right sided chambers is effectively maintained by the “right atrial-tricuspid 
valve-right ventricle complex” and tricuspid annular ring is an essential 
component of this complex. The contractile elements of the right ventricle (RV) 
are predominantly aligned in the longitudinal axis of RV. So, during RV 
systole, the myocardial shortening takes place mainly in the longitudinal plane. 
This systolic longitudinal motion of the RV is best assessed by TAPSE. 
 
RV systolic function by echocardiography: 
RV systolic function can be assessed echocardiographically by various 
parameters. But, the parameters that have been widely accepted and used are 
right ventricular index of myocardial performance (RIMP), TAPSE, two-
dimensional RV fractional area change (2D RV FAC) and tissue Doppler-
derived tricuspid lateral annular systolic velocity (S’). Various cut-off points for 
distinguishing normal and abnormal states for each of the above parameters 
have been defined. In the recent years, the significance of TAPSE in evaluating 
RV function has been validated in many trials beyond doubt. 
Tricuspid annular plane systolic excursion: 
TAPSE is measured using M-mode echocardiography by placing the M-
mode beam along the lateral annulus of the tricuspid valve in the apical-4-
chamber view. The difference in the distance between the tricuspid annulus and 
the RV apex during systole and diastole as obtained in M-mode 
echocardiography gives the measure of TAPSE.  
Normal value for TAPSE is 18mm or above. Values below 17mm is 
considered abnormal RV function. Various studies have shown significant 
correlation between low levels of TAPSE and RV function in many disease 
states including acute myocardial infarction, pulmonary embolism, cor 
pulmonale. Samad et al showed that in patients with first myocardial infarction, 
lower TAPSE levels were associated with worse outcomes and higher mortality 
9
. Their study showed that patients with a TAPSE value < 15mm had a 
significantly high mortality of 45% at 2 years as compared to patients with 
TAPSE levels >20mm who had a low mortality of around 4%. Lower levels of 
TAPSE has been shown to be a predictor of poor outcomes in patients having 
dilated cardiomyopathy and pulmonary hypertension
10
. 
Gupta.S et al in their study to evaluate the interventricular relationships 
and ventricular dyssynchrony in patients with heart failure observed that 
patients with LV systolic dysfunction had significantly reduced levels of 
TAPSE. Patients with bi-ventricular dyssynchrony had the lowest levels of 
TAPSE, and levels were highest for those without any ventricular 
dyssynchrony. The association between TAPSE and LV dyssynchrony was 
found to be independent of the RV and LV ejection fraction. In conclusion, they 
remarked that TAPSE may serve as a useful indicator of LV dyssynchrony, 
especially because it is both easily measurable and reproducible 
11
. 
 
The main advantages of TAPSE are: it is a simple, readily available, 
easily reproducible parameter that can be repeated as needed and does not need 
any specialized echocardiographic machine. But there are certain disadvantages 
of using TAPSE because it measures the longitudinal motion of the RV at one 
plane and assumes that this is reflective of global RV function. Also, TAPSE 
may be angle-dependent and so needs precise alignment of the M-mode beam 
parallel to the RV free wall- tricuspid annulus plane for obtaining correct 
values. Based on the above evidences from various studies, as well the 
advantages, American Society of Echocardiography (ASE) recommends that 
TAPSE should be used routinely as a simple method of estimating RV function, 
with a lower reference value for impaired RV systolic function of 16 mm 
25
. 
MAPSE/TAPSE Ratio 
The left and right ventricular interrelationship is the most important 
physiological mechanism that maintains the cardiovascular homeostasis in 
normal healthy individuals. This relationship may get altered in various disease 
states like ischemic heart disease, acute myocardial infarction, arrhythmias, 
constrictive pericarditis, cardiac tamponade, RV dysfunction due to pulmonary 
hypertension, pulmonary embolism, and cor pulmonale. The assessment of this 
relationship using echocardiography has been an area of interest for many 
decades and various parameters have been described. A novel approach using 
MAPSE/TAPSE ratio has recently been described for the quantitative 
assessment of interventricular systolic relationship 
12
. 
Bruhl et al, in their pilot study, evaluated 51 healthy personnel using 
resting echocardiography for the quantitative assessment of interventricular 
relationship by measuring MAPSE, TAPSE, MAPSE/TAPSE ratio, peak 
annular systolic velocity of left (LVs) and right (RVs) ventricles by M-mode 
and tissue Doppler method
12
. They also further analyzed these parameters for 
variance across age, gender and body surface area (BSA). They found that 
TAPSE was greater than MAPSE by over 54.5% (22.1 ± 2.9 mm vs 14.3 ±2.6 
mm) and MAPSE/TAPSE ratio was 0.66 ± 0.14. These relationships were 
remarkably consistent regardless of age, sex or BSA. Similarly consistent 
results were also noted with the TDI derived parameters. Based on these 
observations, the investigators concluded that MAPSE/TAPSE and LVs/RVs 
ratios are good surrogate measures of left and right ventricular systolic 
relationship and interdependence. 
Bruhl et al, also suggested that, despite the markedly reduced muscle 
mass, the consistently higher RV systolic excursions along the longitudinal 
plane and systolic velocities compared to the LV parameters, was due to the 
relatively low pulmonary vascular resistance against which the RV contracts 
compared to the systemic vascular resistance 
12
.  Also, upto 80% of RV stroke 
volume is due to systolic contraction along its longitudinal axis, while 
contraction along this plane accounts only for 60% of LV stroke volume and the 
rest of the contraction involves circular and torsional movements
13
.  
The normal MAPSE/TAPSE ratio may be altered by disease states 
involving either side of the ventricles. The clinical application of this novel 
parameter involves conditions producing RV dysfunction like pulmonary 
hypertension, acute pulmonary emboli and RV infarctions as well as conditions 
producing LV dysfunction like aortic stenosis, acute myocardial infarction. The 
ratio may also be altered in dyssynchronous ventricular contraction states like 
right (RBBB) and left bundle branch block (LBBB), RV or LV pacing and 
accessory pathway conduction. 
Permanent Pacemaker Implantation (PPI) 
Ever since the development of implantable cardiac pacemakers in the mid 
20
th
 century, cardiac pacing has remained the mainstay of therapy in managing  
patients with both bradyarrhythmias and tachyarrhythmias. In recent years, the 
indications for pacing has been expanded to diseases like drug-refractory heart 
failure and hypertrophic cardiomyopathy. However, the most important 
indications for cardiac pacing are atrioventricular blocks and sick sinus 
syndrome. 
There are various types of pacemakers and they are described by the 
Pacemaker code system developed by the NASPE/BPEG
14  
(Table.A). 
  Table.A   NASPE/BPEG Generic Code for Antibradycardia Pacing 
POSITION I II III IV V 
Category 
Chamber(s) 
paced 
Chamber(s) 
sensed 
Response to 
sensing 
Rate 
modulation 
Multisite 
pacing 
 
O = None O = None O = None O = None O = None 
 
A = Atrium A = Atrium 
T = 
Triggered 
R = Rate 
modulation 
A = 
Atrium 
 
V = 
Ventricle 
V = 
Ventricle 
I = Inhibited 
 
V = 
Ventricle 
 
D = Dual (A 
+ V) 
D = Dual 
(A + V) 
D = Dual (T 
+ I)  
D = Dual 
(A + V) 
Manufacturers’ 
designation 
only 
S = Single 
(A or V) 
S = Single 
(A or V)    
 
Application of magnet over a pacemaker converts the pacemaker 
programming into asynchronous mode of operation like DOO, AOO, or VOO. 
In the case of ICDs, magnet application does not alter the programmed pacing 
function, but does inhibit the detection of ventricular tachycardia (VT) / 
ventricular fibrillation (VF) by the ICDs. 
The various types of pacemakers have their advantages and disadvantages 
that are dependent on the timing cycle of individual pacemaker mode. 
Ventricular Inhibited Pacing (VVI): 
The most commonly used mode in PPI is the VVI mode. VVI pacing 
mode is capable of sensing a ventricular event and responds by inhibiting the 
pacemaker output. VVI pacemakers have a period of refractoriness after a paced 
or sensed ventricular event, during which any ventricular event is not sensed. 
This interval is called the ventricular refractory period. During this period, 
ventricular events do not reset the cycle timing. VVI pacing is especially 
protective in life threatening bradycardias. The main disadvantage of VVI 
pacing mode is the lack of AV synchrony. 
 
Atrial Inhibited Pacing (AAI): 
AAI pacing mode has timing cycles similar to VVI pacing, but the major 
difference is that both pacing and sensing takes place from the atrium and 
responds to a sensed atrial event by inhibiting the pacemaker output. An atrial 
event, either paced or sensed, is followed by a refractory period similar to VVI 
pacing during which no intrinsic atrial event changes delivery of the next pacing 
stimulus. The next atrial pacing stimulus is delivered when the first atrial timing 
cycle ends, irrespective of ventricular events. This occurs because, by 
pacemaker programming, an AAI pacemaker should not sense ventricular 
events. The only exception to this rule is “far-field sensing” where a large 
ventricular signal may inappropriately be sensed by the atrial lead, resulting in 
resetting of the atrial timing. This abnormality can be partially corrected by 
decreasing the sensitivity of the atrial channel or by prolonging the atrial 
refractory period. 
AV Sequential, Non–P-Synchronous Pacing (DDI): 
DDI pacing mode is characterised by dual-chamber sensing, which 
prevents competitive atrial pacing. The response of the DDI ventricular mode is 
inhibition only. There is no tracking of P waves and hence, pacing occurs only 
at the programmed rate. DDI is rarely a preferred mode, but it is still a 
programmable option in most of the current dual-chamber pacemakers. The 
DDI pacing mode can be particularly helpful during intermittent atrial 
tachyarrhythmia as it results in atrial undersensing and thereby prevents mode 
switching. 
Dual-Chamber Pacing and Sensing with Inhibition and Tracking (DDD):  
In the DDD mode, the basic timing circuit associated with lower rate 
pacing is divided into two intervals: the ventriculoatrial (VA) interval and the 
atrioventricular interval (AVI). The AVI results in AV sequential pacing, which 
is initiated by pacing producing subsequent intrinsic ventricular conduction. 
Alternately, it may be initiated by a native P wave producing subsequent 
ventricular pacing. 
Rate-Adaptive Sensors:  
Incorporation of rate-adaptive sensor in the pacemaker provides rate 
responsiveness when the sensor is on, based on changes in the level of physical 
activity. Rate-adaptiveness of a pacing mode is represented by adding an R in 
the fourth position of the code (e.g., VVIR, AAIR, DDIR, and DDDR). The 
sensors most commonly used are the accelerometer which is based on activity, 
and minute ventilation, based on measuring transthoracic impedance. 
Right ventricular apical pacing with VVI mode 
Due to the ease of site accessibility and stability of the pacemaker lead, 
the pacing lead in the endocardium is traditionally positioned at the right 
ventricular apex. In general, patients tolerate pacing from the RV apical position 
very well and is effective in relief of symptoms. However, it is now known that 
adverse effects, may arise from RV apical pacing, on cardiac structure and LV 
function
15
. This may be related to the altered electrical and mechanical 
activation pattern of the ventricles (i.e, ventricular dyssynchrony) caused by RV 
apical pacing. 
Altered ventricular activation sequence in RV apical pacing: 
During RV apical pacing, the electrical activation sequence of the 
ventricles is altered. The RV apex where the lead is positioned is activated first, 
followed by the spread of the electrical impulses to other regions of the right 
and left ventricle. This spread of electrical activation takes place through the 
ventricular myocardium and not through the His-purkinje conduction system. 
The result of this abnormal spread of the electrical wave front is slow 
propagation and also heterogenous mechanical activation of the ventricles, 
similar to that of LBBB. The consequence of this abnormal activation, is that, 
the total time required for activation of the entire ventricular myocardium, 
expressed as QRS duration, is at least twice that during normal sinus rhythm. In 
most cases, the site of earliest mechanical activation is the interventricular 
septum. This single breakthrough at the interventricular septum is followed by 
abnormal activation of other regions of the ventricles and the last part of 
activation at the inferoposterior base of the LV
16
.  
RV apical pacing thus results in changes, not only of the initiation of 
mechanical contraction, but also in the sequence of mechanical contraction. The 
regions of the RV that are near the pacing site and hence are activated early 
show early meachanical coupling with rapid systolic contraction. This causes 
the regions that are activated later to be stretched due to this early contraction. 
These regions that are late-activated, thereby undergo a delayed systolic 
shortening which, in turn imposes systolic stretch, to the early activated regions 
that are at present undergoing premature relaxation. The end result of these 
abnormal contraction patterns involving different regions of the LV is a 
redistribution of myocardial strain and work which produces a contraction that 
is comparatively less effective. 
RV apical pacing and its detrimental effects: 
The altered sequences of electrical activation and mechanical contraction 
of the ventricles in RV apical pacing may result in a variety of detrimental 
effects on the metabolism, perfusion dynamics, remodelling, hemodynamics 
and mechanical function. Long-term RV apical pacing can cause changes in 
both regional perfusion and oxygen demands of the myocardium, resulting in 
myocardial perfusion defects, mainly in regions near the pacing site, in upto 
65% of patients even in the absence of underlying obstructive coronary artery 
disease (CAD). 
Chronic RV apical pacing may also cause abnormal LV remodelling, like 
asymmetrical hypertrophy of the RV and LV myocardium. The regions of 
myocardium that are activated early undergo thinning while the late-activated 
regions undergo thickening. The abnormal contraction sequence may result in 
ventricular dilation during long-term RV pacing. Progressive LV dilation may 
also cause functional mitral regurgitation that also gradually worsens. Left atrial 
(LA) remodelling is another consequence of chronic RV pacing that may result 
in heterogeneity in atrial electrical excitation with resultant atrial fibrillation.  
Histopathological changes in the ventricular myocardium include 
intercellular and intracellular alterations showing myofiber disarray and 
degenerative fibrosis, variations in the mitochondrial organisation, abnormal 
expression of myocardial contractile proteins. There also occurs a gradual 
reduction in protein kinases and proteins associated with calcium homeostasis
17
.  
Abnormality in the sequence of electrical and mechanical activation of 
the LV may result in global mechanical dysfunction and associated adverse 
hemodynamic properties. Pacing at the RV apex and associated dyysynchrony 
results in longer durations of the isovolumic contraction (IVC) and isovolumic 
relaxation (IVR) phases of the cardiac cycle. This may result in altered filling 
and contractile properties of the LV with a resultant decrease in cardiac output. 
Alterations in myocardial strain and timing of regional strain also may occur 
during RV apical pacing resulting in varying degrees of mechanical 
dyssynchrony. 
Evidence from Pacing Mode Trials: 
The association between a high percentage of RV apical pacing and 
adverse clinical outcomes has been shown by a number of large randomized 
clinical trials on pacing mode selection.  
The investigators of the MOST (Mode Selection Trial), through a 
substudy, concluded “ strong association between RV pacing and the risk of 
hospitalization due to heart failure and atrial fibrillation in patients who had 
both the physiological dual-chamber pacing (DDDR) and single-chamber 
ventricular pacing [VVIR]”18. It was noted that ventricular pacing for more than 
40% of the time in the DDDR group was associated with an increased risk of 
hospitalization for heart failure (hazard ratio [HR]: 2.60; 95% confidence 
interval [CI]: 1.05 to 6.47; p< 0.05). Similarly, ventricular pacing for more than 
80% of the time in the VVIR group was also associated with a higher risk of 
heart failure hospitalization (HR: 2.50; 95% CI: 1.44 to 4.36; p< 0.05). The 
results of the MOST study demonstrated that the cumulative percentage of 
ventricular pacing is a strong predictor of hospitalization for heart failure in 
patients with a normal baseline QRS duration. There was also a linear 
association between the cumulative percentage of ventricular pacing and an 
increased risk of atrial fibriilation. 
In the DAVID (Dual Chamber and VVI Implantable Defibrillator)  trial
19
, 
patients with underlying indication for defibrillator implantation, but without 
any indication for antibradycardia pacing, were randomized to receive either 
physiologic pacing  using  DDDR mode with lower rate of 70 beats/ min or 
ventricular backup pacing using VVIR mode with lower rate of 40 beats/min. 
The median follow-up period was 8.4 months. The primary outcome measures 
studied were: (i) freedom from death and (ii) absence of hospitalization for new 
or worsened heart failure.  These outcomes were lower in the VVIR group than 
in the DDDR  group (relative hazard: 1.61; 95% CI: 1.06 to 2.44; p< 0.03). 
Importantly, the investigators noted that patients with a high pacing percentage 
at the 3-month follow-up had a pattern toward a worse survival at 12 months
 19
. 
The above trials concluded that there is absence of any clinical benefit of 
physiologic DDDR pacing over VVIR. The reason for the absence of significant 
benefit in these studies was explained by the short programmed AV interval that 
caused a higher percentage of ventricular pacing in the DDDR groups. Thus, the 
beneficial effect of maintaining AV synchrony  by physiologic DDDR pacing 
may be neutralized by the deleterious effects due to RV apical pacing itself.  
Unfortunately, these trials did not provide conclusions about the exact 
amount of RV apical pacing that is associated with negative effects on the 
cardiac function. Ventricular pacing, by means of maintaining physiologic AV 
synchrony, may in reality be beneficial to a certain extent. But, certain patient 
populations are more likely to be prone to the negative effects of RV apical 
pacing , especially, patients with underlying conduction disorder, ischemic heart 
disease, patients requiring pacing for a longer period of time and patients with 
reduced LV function at baseline
20
.  
Mechanisms of mechanical dyssynchrony during RV apical pacing: 
Mechanical dyssynchrony secondary to right ventricular apical pacing 
can result in both interventricular dyssynchrony as well as intraventricular 
dyssynchrony.  
The extent of ventricular dyssynchrony and the activation sequence 
during abnormal conduction are determined, at least by four myocardial 
properties which as follows: 
a)  Myocardial fibers conduct electrical impulses slower by up to four 
times compared to conduction through the Purkinje system. 
b)  Velocity of conduction along the length of the muscle fibers is 
approximately two times than perpendicular to them. Therefore, 
the  pacing site is surrounded by an elliptical-shaped wave front,  
particularly in the epicardial and midmyocardial layers
21
. 
c) Reentry of impulses that originate from the working myocardium 
into parts of the rapidly conducting His-Purkinje system is rare. 
Even   though Purkinje-myocardial junctions are present to 
facilitate the           transmission of electrical impulses 
from the conduction system into the  myocardium, the reverse is 
not true. So, in majority of cases, the myocardial activation 
sequence during ventricular pacing is determined predominantly by 
slow conduction through the normal   myocardium, away from the 
pacing site. 
d)  Conduction of impulses through most of the endocardial fibers is 
faster  than the rest of the LV wall fibers. Also, the circumference 
of the endocardium is  smaller than its epicardial counterpart. 
So, total  electrical activation time is shorter with LV endocardial 
pacing compared with LV epicardial pacing
22
. 
In heart failure patients, an increased risk of cardiac morbidity and 
mortality has been proven in the presence of ventricular dyssynchrony. In 
addition, the LV systolic function and functional capacity of the patients is also 
reduced in patients with mechanical dyssynchrony following long term RV 
apical pacing. Cardiac resynchronization therapy (CRT) results in normalization 
of LV systolic function by restoring the synchronized cardiac contraction 
thereby improving the functional capacity
23
. This suggests that there is a direct 
relationship between abnormal activation pattern (LBBB-like pattern) during 
RV apical pacing or ventricular dyssynchrony and a deterioration of LV 
function. Therefore, valuable information can be obtained from assessing 
ventricular dyssynchrony by echocardiography in patients with VVI pacing. 
 
 
 
 
 
 
MATERIALS AND METHODS 
This was a prospective case control study done between March 2012 and 
February 2013 at the department of cardiology, Government General Hospital 
Chennai. The study cohort comprises of 40 patients, who had permanent 
pacemaker implantation done (RV apical pacing with VVI mode) more than one 
year back, who attended the Pacemaker clinic of our department for follow-up. 
The patients with the presence of any comorbid conditions like diabetes 
mellitus, hypertension, ischemic heart disease were excluded from the study. 
The control group consists of 30 age matched healthy individuals. Patients and 
controls both belonged to the age group of 30- 75 years. Informed, written 
consent was obtained from all the patients and controls. The study protocol was 
evaluated and approval was obtained from the Institutional Ethics Committee. 
Inclusion criteria: 
All patients with VVI pacemaker implantation (with RV apical pacing) 
done between one to two years before the start of the study period. 
Exclusion criteria: 
1. Known case of  IHD, MI or regional wall motion abnormalities 
2. Known case of cardiomyopathy, heart failure or LV dysfunction 
3. Known case of valvular heart disease 
4. Diabetes mellitus 
5. Hypertension 
6. Chronic kidney disease 
7. Chronic lung disease 
Patient evaluation: 
All of the 40 patients and controls were subjected to the following    
assessment: 
1. Detailed history taking 
2. Thorough clinical examination 
3. Standard 12-lead electrocardiogram, especially the paced QRS 
(pQRS)  duration 
4. Echocardiographic evaluation 
Echocardiographic examination:  
Echocardiographic examination was done with a 2.5 MHz transducer 
using the Esaote myLab equipment available in our Echo lab. The examination 
was done with the patients in the left lateral decubitus position. 
Echocardiographic examination and measurements were recorded according to 
the American Society of Echocardiography recommendations 
(24- 25)
.  
The LV end diastolic and end systolic volumes were measured from the 
apical 4- and 2- chamber views using the modified Simpson method and LV 
ejection fraction was calculated from the volumes obtained. The patients were 
analyzed under two groups: normal (LV EF>55%) and reduced (LV EF <55%) 
LV systolic function.  Presence of LV diastolic dysfunction was assessed in the 
apical 4-chamber view with the pulsed wave Doppler sample placed at the 
mitral inflow region. The presence of any associated mitral regurgitation was 
noted by the standard protocols. Mitral (MAPSE) and tricuspid (TAPSE) 
annular plane systolic excursions were measured in the apical 4-chamber view 
by placing the M-mode cursor along the lateral annulus of the mitral and the 
tricuspid valves. The difference in the distance between the mitral annulus and 
the LV apex during systole and diastole was obtained in M-mode 
echocardiography to get MAPSE. Similar measurements of the tricuspid annular 
excursions during systole and diastole were obtained to get TAPSE. The 
MAPSE/TAPSE ratio was calculated from the above values. MAPSE value of 
10mm or less and TAPSE value of 16mm or less were considered abnormal. 
Based on the suggestions by Bruhl et al and the observed values of controls in 
our study, a MAPSE/TAPSE ratio of <0.64 was taken as the cut-off for the 
presence of interventricular dyssynchrony.  
Baseline demographic and clinical characteristics for continuous 
variables were expressed as mean ± SD and tested for differences using the 
Student’s t-test. The study population was also divided into 3 groups based on 
age including those < 40 years, 40-60 years, and > 60 years old as well as by 
sex. Comparison of multiple echo measurements across age groups was done by  
Analysis of variance (ANOVA).  For all measurements, a two-sided P-value of 
less than0.05 was considered statistically significant. All statistical analysis was 
performed using SPSS for Windows, version 17.0, SPSS Inc, Chicago, Illinois, 
USA. 
 
  
 
 
 
 
 
 
 
 
 
RESULTS 
The study population included 40 patients with VVI pacemaker 
implantation and 20 healthy controls. The average age of the patients was 50.35 
± 11.28 years and of the control group was 49.21± 8.82 years.  The average 
percentage of males and female in both the groups was 55% and 45% 
respectively (Fig.1). There was no difference in the age or sex distribution 
between the two groups. Baseline profile and echocardiographic parameters of 
the study population is given in Table.1. 
Fig.1:
 Stacked bar diagram showing the percentage of sex distribution among  the 
study population. 
 
Among the 40 patients, 28 (70%) patients had CHB and 12 (30%) 
patients had SSS as the underlying conduction disorder for pacemaker 
implantation (Fig.2). All the patients had undergone pacemaker implantation 
before 1 to 2 years from the start of the study period. The average pQRS 
duration in the patient group was 162.5 ± 8.39 msec and in the control group 
was 107.05 ± 11.18 msec (P<0.0001). 
   
Fig.2 showing the percentage distribution of patients having underlying CHB  and SSS 
 
 
 
     
   Table.1 Baseline characteristics 
Characteristics Patients (n=40) Controls (n=20) P value 
Age (years) 50.35 ± 11.28 49.21 ± 8.82 0.069 
Sex 
     Males  
     Females 
 
23 (57.5%) 
17 (42.5%) 
 
11 (55%) 
9 (45%) 
 
 
Indication for 
Pacemaker 
     CHB 
     SSS 
 
 
28 (70%) 
12 (30%) 
 
 
 
- 
- 
 
pQRS duration 
(msec) 
162.5 ± 8.39 107.05 ± 11.18 <0.0001 
Echocardiographic 
parameters: 
     LV EDV (ml) 
     LV ESV (ml) 
     LV EF (%) 
     LV DD: 
          Grade 1 
          Grade 2 
          Grade 3 
          Grade 4 
     MR severity: 
          Mild 
          Moderate 
          Severe 
     MAPSE (mm) 
     TAPSE (mm) 
   MAPSE/TAPSE 
ratio 
 
 
 
 
 
 
125.9 ±  24.87 
58.94 ±  20.94 
53.64 ±  9.93 
 
5 (12.5%) 
- 
2 (5%) 
- 
 
2 
2 
1 
13.11 ± 1.72 
20.57 ± 2.62 
0.639 ± 0.039 
 
 
117.68 ± 26.54 
47.03 ± 12.12 
60.05 ± 4.41 
 
2 (10%) 
- 
- 
- 
 
- 
- 
- 
13.92 ± 0.54 
21.13 ± 1.36 
0.659 ± 0.01 
 
 
0.242 
0.022 
0.008 
 
 
 
 
 
 
 
 
 
0.045 
0.371 
0.028 
 
(CHB- Complete heart block, SSS- Sick sinus syndrome, EDV- End diastolic volume, 
ESV-End systolic volume, EF- Ejection fraction, DD- Diastolic dysfunction, MR- Mitral 
regurgitation, MAPSE- Mitral annular plane systolic excursion, TAPSE- Tricuspid annular 
plane systolic excursion, pQRS – paced QRS) 
The LV systolic function assessed by EF in the patient group was reduced 
significantly compared to the controls (53.64 ± 9.93% vs 60.05 ± 4.41%; P = 
0.008). Among the 40 patients, 15 (37.5%) had reduced EF <55% suggesting 
underlying LV systolic dysfunction. The mean MAPSE was 13.11 ± 1.72 mm in 
the patients compared with average MAPSE of 13.92 ± 0.54mm (P = 0.045) in 
control groups. LV diastolic dysfunction of grade 3 was noted in 2 patients (5%) 
with pacemaker who had severe LV dysfunction . There was no severe LV 
diastolic dysfunction  in the control group. 
The mean TAPSE values, suggestive of RV systolic function, were also 
lesser in the patient group compared to the controls, though not statistically 
significant (20.57 ± 2.62 vs 21.13 ± 1.36; P=0.374).  
The average MAPSE/TAPSE ratio in the normal healthy controls was 
0.659 ± 0.01and 0.63 ± 0.033 in the patiens (P=0.028). As mentioned 
previously, a cut-off value of 0.64 for MAPSE/TAPSE ratio was taken as 
suggestive of ventricular dyssynchrony. The patients were further subdivided 
into two groups: MAPSE/TAPSE ratio below 0.64, and equal to or above 0.64, 
and correlation of these values with other echocardiographic parameters of 
ventricular functions were analyzed. 
 
 
Table.2 Measured pQRS duration and echocardiographic variables by age. 
Parameters Age <40 
years 
(n=8) 
Age 40-60 
years 
(n=24) 
Age >60 
years 
(n=8) 
P value 
(ANOVA) 
pQRS duration 
(ms) 
155.62 ± 4.95 162.08 ± 6.90 170.62 ± 9.03 0.001 
LV EF (%) 58.7 ± 6.17 55.51 ± 7.96 42.96 ± 11.47 0.001  
MAPSE (mm) 14.06 ± 0.87 13.45 ± 1.42 11.12 ± 1.77 0 
TAPSE (mm) 22.57 ± 1.24 20.81 ± 2.34 17.83 ± 2.31 0 
MAPSE/TAPSE 
ratio 
0.63 ± 0.033 0.64 ± 0.038 0.62 ± 0.04 0.431 
 (ANOVA- Analysis Of  Variance) 
Patients with VVI pacing were divided into three age groups of less than 
40 years, 40-60 years and more than 60 years (Table.2) and the multiple 
Echocardiographic parameters were analyzed by ANOVA.  There was a 
statistically significant correlation for increasing age with QRS duration on the 
ECG and LV EF (Fig.3). Patients with age above 60 years had markedly 
prolonged pQRS duration (mean: 170.62 ± 9.03 msec) thereby increasing the 
risk of electrical dyssynchrony and also reduced LV EF (mean: 42.96 ± 11.47 
%) compared to the other age groups. No significant association between age 
and MAPSE, TAPSE or MAPSE/TAPSE ratio was noted. 
  
Fig.3 showing the relationship between increasing age, paced QRS duration and LV 
function 
Table.3 Measured pQRS duration and echocardiographic variables by gender 
 Male 
(n=23) 
Female 
(n=17) 
P value 
pQRS duration 
(ms) 
163.26 ± 7.77 162.77 ± 10.60 0.86 
LV EF (%) 53.98 ± 8.61 51.54 ± 13.33 0.48 
MAPSE (mm) 13.44 ± 1.69 12.49 ± 1.80 0.097 
TAPSE (mm) 21.06 ± 2.43 19.61 ± 2.98 0.098 
MAPSE/TAPSE 
ratio 
0.64 ± 0.038 0.63 ± 0.041 0.431 
There was no difference either in the pQRS duration or echo derived 
variables of ventricular function/ dyssynchrony and gender (Table.3). 
Table.4 Measured pQRS duration and echocardiographic variables by 
indication for pacemaker 
 CHB 
(n=28) 
SSS 
(n=12) 
P value 
pQRS duration 
(ms) 
162.5 ± 9.37 162.5 ± 5.83 1.00 
LV EF (%) 52.33 ± 11.25 56.69 ± 4.97 0.207 
MAPSE (mm) 12.74 ± 1.86 13.97 ± 0.89 0.036 
TAPSE (mm) 20.38 ± 2.93 21.00 ± 1.71 0.499 
MAPSE/TAPSE 
ratio 
0.62 ± 0.03 0.66 ± 0.02 0.0001 
 (CHB- Complete heart block, SSS- Sick sinus syndrome) 
 The underlying indication for pacemaker implantation did show an 
influence on ventricular synchrony (Table.4). Patients who had underlying CHB 
had a lower MAPSE levels compared with patients who had SSS (12.74 ± 1.86 
vs 13.97 ± 0.89; P = 0.036). They also had a more marked reduction in the 
MAPSE/TAPSE ratio than the SSS group (0.62 ± 0.03 vs 0.66 ± 0.02; P = 
0.001). 
 
 
 
Table.5 Measured echocardiographic variables by pQRS duration 
 
 QRS duration ≤ 
165 ms (n=33) 
QRS duration > 
165 ms 
(n=7) 
P value 
LV EF (%) 57.25 ± 5.93 39.17 ± 9.75 <0.0001 
MAPSE (mm) 13.72 ± 1.18 10.66 ± 1.33 <0.0001 
TAPSE (mm) 21.52 ± 1.83 16.75 ± 1.57 <0.0001 
MAPSE/TAPSE 
ratio 
0.639 ± 0.039 0.635± 0.041 0.80 
 
Patients with marked prolongation of the pQRS duration (>165 ms) had 
lower LV EF (39.17 ± 9.75 vs 57.25 ± 5.93; P <0.001) than patients with lesser 
degrees (< 165 ms) of pQRS prolongation (Table.5 and Fig.4).  
   
Fig.4 showing the relationship between paced QRS duration, LV and RV function 
Both MAPSE and TAPSE were also significantly reduced in patients with 
pQRS duration >165ms as compared to patients with pQRS duration < 165 ms. 
However, there was no difference in the MAPSE/TAPSE ratio between the two 
groups. 
 
 
 
 
 
Table.6 Measured pQRS duration and echocardiographic variables by LVEF 
 
 
 
LV EF ≥55% 
(n=25) 
LV EF <55% 
(n=15) 
P value 
pQRS duration 
(ms) 
158.8 ± 5.25 168.66 ± 9.15 <0.0001 
MAPSE (mm) 14.1 ± 0.66 11.46 ± 1.69 <0.0001 
TAPSE (mm) 22.12 ± 0.87 17.98 ± 2.52 <0.0001 
MAPSE/TAPSE 
ratio 
0.637 ± 0.037 0.64 ± 0.043 0.81 
 (LV EF- LV ejection fraction) 
 When patients were analyzed based on the presence of normal 
LVEF (>55%) and reduced LVEF (<55%), the paced pQRS duration, MAPSE 
and TAPSE were significantly reduced in the group with LV dysfunction 
compared with the group with normal LV function (Table.6 and Fig.5 & 6). 
However, there was no difference in the MAPSE/TAPSE ratio between the two 
groups. 
 
 
 
 
     
 
 
 
 
 
 
Fig.5 showing the linear relationship between LVEF and MAPSE.  
   
 
 
 
 
 
 
Fig.6 showing the linear relationship between LVEF and TAPSE 
    
Fig.7 showing percentage of patients with LV dysfunction by MAPSE 
Out of the 40 patients studied, 4 patients (10%) had MAPSE <10 mm 
suggestive of LV dysfunction (Fig.7) 
          
Fig.8 showing percentage of patients with RV dysfunction by TAPSE 
The same 4 patients had TAPSE <16mm suggestive of associated RV 
dysfunction (Fig.8). 
Table.7 Measured pQRS duration and echocardiographic variables by 
MAPSE/TAPSE ratio 
 
MAPSE/TAPSE 
ratio <0.64 
(n=19) 
MAPSE/TAPSE 
ratio >0.64 
(n=21) 
P value 
LV EDV (ml) 130.43 ± 24.88 121.82 ± 24.73 0.279 
LV ESV (ml) 63.37 ± 23.61 54.92 ± 17.83 0.206 
LV EF (%) 52.75 ± 10.30 54.44 ± 9.77 0.059 
pQRS duration (ms) 162.89 ± 9.32 162.14 ± 7.67 1.00 
 
The patients were then subdivided into two groups based on the 
MAPSE/TAPSE ratio: patients with LV dyssynchrony (ratio <0.64) and no LV 
dyssynchrony(ratio > 0.64) and, relationship if any, with pQRS duration, LV 
functional parameters was assessed.  Nearly 50% (19) of the patients had 
MAPSE/TAPSE ratio <0.64 suggesting the presence of  some degree of LV 
dyssynchrony. But, there was no statistically significant difference noted 
between the two groups in these variables (Table.7). However, there was a trend 
towards an association between lower MAPSE/TAPSE ratio and reduced LV 
EF (Fig.9).                                                              
   
 
 
  
 
 
 
 
Fig.9 showing the linear relationship between MAPSE/TAPSE ratio and LVEF 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
Single chamber RV pacing using VVI pacemaker is the most common 
type of pacemaker implantation done worldwide for various conduction 
disorders. The advantages of VVI pacing, in terms of survival benefit is well 
known. But, long term RV apical pacing is also associated with detrimental 
effects on the cardiac structure and function.  Prior studies have showed the 
adverse effects of RV apical pacing on both LV and RV function. Chronic RV 
apical pacing is also known to result in some degree of ventricular 
dyssynchrony due to the altered electrical activation pattern. 
Chronic VVI pacing and LV function 
Paxinos G et al, in their study, evaluated LV function in patients with sick 
sinus syndrome who had undergone VVI pacing and showed that VVI pacing in 
the long term resulted in reduction in LV EF
26
. In our study, all the patients 
studied had undergone pacemaker implantation between 1 to 2 years before the 
start of the study. The patient group had a lower LV EF compared to the control 
group (53.64 ± 9.93% vs 60.05 ± 4.41%; P = 0.008). This shows that the 
reduction in LV function can be noted as early as 1 year after implantation.  
 
 
Determinants of LV dysfunction in VVI pacing 
Among the patients with VVI pacing, in our study, LV dysfunction as 
assessed by reduced LV EF (<55%) was present in 15 (37.5%) patients.  The 
major factors affecting the reduction in LV function were the paced QRS 
duration, age of the patient and underlying prior CHB. 
The paced QRS complex duration is a major determinant in the adverse 
effects of chronic VVI pacing. Su Y et al, proved in their study that paced QRS 
duration ≥ 180 ms is associated with progressive LV dilation and worsening LV 
EF
27
. In our study also, the patients with paced QRS duration >165 ms had 
significant reduction in the LV EF, MAPSE and TAPSE compared to patients 
with lesser duration of paced QRS complex.  
Advancing age was a major determinant affecting LV function. Those 
patients above the age of 60 years had more marked prolongation of the paced 
QRS complex and higher reduction in the LV EF. The biventricular function 
assessment did not show significant difference between males and females.  
 
In our study, patients with underlying CHB as the indication for 
pacemaker implantation had significantly lower MAPSE and MAPSE/TAPSE 
ratios compared to patients with SSS. This difference may possibly be due to 
the fact that in patients with CHB, there is uninterrupted pacing discharge from 
the VVI pacemaker to maintain the heart rate. As a result of this, the ventricles 
are continuously contracting out of phase, resulting in early onset of LV 
dysfunction. In contrast, the presence of intermittent intrinsic rhythm in patients 
with sick sinus syndrome, reduces the repetitive pacing discharges; thereby 
lowering the detrimental effects of chronic VVI pacing on the ventricular 
function. 
Mitral regurgitation in VVI pacing  
The development of mitral regurgitation of varying degrees in VVI 
pacing had been demonstrated in previous studies
29
. In our study also, moderate 
to severe MR was present in 3 (8%) patients.  It was demonstrated by Sassone B 
et al that the functional MR developing in pacemaker implantation was due to 
the presence of both AV dyssynchrony and alteration in the ventricular 
activation sequence, with the latter playing the major role
30
. 
 
Role of MAPSE and TAPSE 
Those patients with reduced LV EF <55% had significantly increased 
QRS duration compared to patients with normal LV function. There was a 
linear correlation between levels of LV EF below 55% and reduction in MAPSE 
and TAPSE; lower the LV EF, lower were the MAPSE and TAPSE levels. 
The usefulness of MAPSE as a surrogate marker of  LV systolic function 
was demonstrated previously by Pai R G et al
28
. In our study, 10% of 
pacemaker group had reduced MAPSE (<10mm) and there was a linear 
correlation between MAPSE levels and reduced LV EF. These 10% patients 
also had lower TAPSE (<16mm) possibly due to biventricular dysfunction as a 
result of ventricular dyssynchrony.  
In our study, the absolute value of TAPSE was more than MAPSE in both 
the patient and control by around 50%. This further favours the previous 
conclusion by various studies
(12-13)
 that the tricuspid annular plane systolic 
movement is more than mitral annular movement during systole. This is 
explained by the predominant systolic movement of the RV along its 
longitudinal axis compared to the LV systolic movement along longitudinal, 
circular and radial axis
13
. 
MAPSE/TAPSE ratio and interventricular dyssynchrony in VVI pacing 
Bruhl et al concluded in their study that concluded that MAPSE/TAPSE 
and LVs/RVs ratios are good surrogate measures of left and right ventricular 
systolic relationship and interdependence
12
. In their study, MAPSE/TAPSE 
ratio was 0.66 ± 0.14 in normal healthy individual and concluded that reduced 
levels of this ratio can be used to study interventricular relationship and 
ventricular dyssynchrony. In our study, the average MAPSE/TAPSE ratio in the 
normal healthy controls was 0.659 ± 0.01and 0.63 ± 0.033 in the patients 
(P=0.028). Based on the above studies, a cut-off value of 0.64 for 
MAPSE/TAPSE ratio was taken as the cut-off suggestive of LV dyssynchrony. 
The patients were further subdivided into two groups: MAPSE/TAPSE ratio 
below 0.64 and above 0.64, and correlation of these values with other 
echocardiographic parameters of ventricular functions were analyzed. There 
was no statistically significant difference noted between the two groups in these 
variables. However, there was a trend towards a linear association between 
lower MAPSE/TAPSE ratio <0.64 and reduced LV EF, thus strongly favouring 
the direct relationship between LV dyssynchrony and worsening LV function. 
 
 
 
 
 
 
 
 
 
LIMITATIONS OF THE STUDY: 
1. All of the pacemaker patients had undergone VVI implantation 
only between 1 to 2 years before the start of the study. The effect of VVI pacing 
in patients with longer duration (>2 years) of implantation was not done. 
2. Even though the linear correlation between lower LV EF and 
ventricular dyssynchrony by MAPSE/TAPSE ratio was shown, no statistically 
significant association between the two variables could be demonstrated. This 
might have been overcome by a larger study population. 
3. Even though M-mode and 2D echocardiography was done for 
measuring the variables in our study, the current Echo method of choice for 
assessing ventricular function and wall motion is TDI with strain rate imaging. 
  
 
 
 
 
 
 
   CONCLUSIONS 
1. Chronic VVI pacing from RV apex is associated with varying degrees of 
LV and RV dysfunction. 
2. The degree of prolongation of the paced QRS duration is a powerful 
determinant of worsening ventricular function. 
3. Advanced age is associated with both a marked prolongation of the paced 
QRS duration and progressive ventricular dysfunction in patients with 
VVI pacing. 
4. MAPSE and TAPSE are useful parameters for quickly assessing LV and 
RV functions in VVI pacing. 
5. LVEF and MAPSE/TAPSE ratio have linear correlation for LV 
dysfunction in VVI pacing. 
6. MAPSE/TAPSE ratio is a novel indicator of ventricular dysfunction and 
lower levels are suggestive of associated interventricular dyssynchrony. 
However, this ratio needs further validation by larger randomized studies. 
 
 
 
            
  
 
 
 
 
 
 
 
 
 
 
 
Fig.A showing Apical 4-chamber view for measuring MAPSE. The M-
mode cursor placed along the lateral annulus of the mitral valve 
Fig.B showing Apical 4-chamber view for measuring TAPSE. The M-
mode cursor placed along the lateral annulus of the tricuspid valve 
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ABBREVIATIONS AND ACRONYMS 
 
AAI  : Atrial inhibited pacing 
APC  : Atrial premature contraction 
ATP  : Adenosine triphosphate 
AV  : Atrioventricular 
BNP  : Brain natriuretic peptide 
CHB  : Complete heart block 
CRT  : Cardiac resynchronization therapy 
CICR  : Calcium induced calcium release 
DD  : Diastolic dysfunction 
DDI  : AV sequential, Non-P synchronized pacing 
DDD  : Dual chamber pacing and sensing with inhibition and 
  tracking 
DFT  : Diastolic filling time 
EDV  : End diastolic volume 
EF  : Ejection fraction 
ESV  : End systolic volume 
FAC  : Fractional area change 
IMP  : Index of myocardial performance 
IVMD : Interventricular mechanical delay 
IVR  : Isovolumic relaxation 
LBBB : Left bundle branch block 
LV  : Left ventricle 
MAPSE : Mitral annular plane systolic excursion 
NCX  : Sodium-calcium exchanger pump 
PPI  : Permanent pacemaker implantation 
RBBB : Right bundle branch block 
RV  : Right ventricle 
SA  : Sinoatrial 
SERCA : Sarcoplasmic reticulum calcium ATPase 
SPWMD : Septal-to-posterior wall motion delay 
SSS  : Sick sinus syndrome 
SVC  : Superior vena cava 
TAPSE : Tricuspid annular plane systolic excursion 
TDI  : Tissue Doppler imaging 
VT  : Ventricular tachycardia 
VVI  : Ventricular inhibited pacing 
 
 
 
 
 
 
 
 
 
 
       PROFORMA 
               CD No: 
Name:                   Age:           Sex: 
Year of pacemaker implantation: 
PR: 
BP: 
ECG: 
 
Echo parameters: 
LVEDV (ml):   LVESV (ml):    LV EF (%): 
LV DD: 
MR severity: 
TR: 
RVSP: 
MAPSE (mm): 
TAPSE (mm): 
MAPSE/ TAPSE ratio: 
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TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSIONS 
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Co-Investigator(if any): 
Name of Participant: 
Site :   RGGGH& MMC, Chennai 
You are invited to take part in this research/ study/procedures/tests. The information in this 
document is meant to help you decide whether or not to take part. Please feel free to ask if 
you have any queries or concerns. 
What is the purpose of research? 
Despite the differences in the right and left ventricles in shape and myocardial contractile 
element density, the synchronous electrical excitation and mechanical contraction of both the 
ventricles and the ventricular interdependence maintains the biventricular function in balance. 
VVI pacemaker implantation with RV apical pacing disturbs this balance by abnormal 
electrical and mechanical activation of the ventricles (or ventricular dyssynchrony) with 
detrimental effects on cardiac structure and left ventricular (LV) function 
Echocardiographic evaluation of LV and RV systolic function by measuring MAPSE and 
TAPSE and their ratio (MAPSE/TAPSE ratio) has been shown to correlate with ventricular 
synchrony in normal healthy individuals. So,in our study we are using the M-mode echo 
measurement of MAPSE, TAPSE, and their ratio to obtain information regarding the degree 
of ventricular dyssynchrony in patients with VVI pacing. 
We have obtained permission from the Institutional Ethics Committee.  
The study design 
It is a prospective case control study. 
Study Procedures 
• The study involves evaluation of detailed history along with clinical presentation and 
assessment of echocardiographic parameters, including LV and RV function assessment 
by MAPSE, TAPSE and MAPSE/TAPSE ratio for evaluating ventricular dyssynchrony in 
patients with VVI pacemaker implantation. 
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law like the Drug Controller General of India to view your data, if required. 
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meetings, will not reveal your identity. 
How will your decision to not participate in the study affect you? 
Your decision not to participate in this research study will not affect your medical care or 
your relationship with the investigator or the institution. You will be taken care of  and you 
will not loose any benefits to which you are entitled.  
Can you decide to stop participating in the study once you start? 
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MITRAL  AND TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSIONS 
Patient may check () these boxes. 
PARTICIPANT NAME :      DATE:                           
 AGE:                                         SEX:         C.D.NO. : 
 
1. The details of the study have been provided to me in writing and explained to me 
in my own language. 
 
2. I confirm that I have understood the purpose of the above study. I have the 
opportunity to ask the question and all my questions and doubts have been 
answered to my complete satisfaction. 
 
3. I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time without giving any reason, without my legal rights being 
affected. 
 
 
4. I understand that investigator, the institution, regulatory authorities and the ethical 
committee will not need my permission to look at my health records both in 
respect to the current study and any further research that may be conducted in 
relation to it, even if I withdraw from the study. I understand that my identity will 
not be revealed in any information released to third parties or published, unless as 
required under the law. I agree not to restrict the use of any data or results that 
arise from this study.  
 
5. I hereby consent to, undergo complete physical examination ,and diagnostic tests 
including hematological, biochemical, radiological and urine examinations 
 
6. I have been given an information sheet giving details of the study . 
 
7. I hereby consent to participate in the above study  
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Name Age (yrs) Sex QRS durn ms) EDV (ml) ESV (ml) LV EF (%) LV DD MR MAPSE (mm) TAPSE (mm) MAPSE/TAPSE Ratio
Rajendran 52 M 114 142 54 61 NIL NIL 14.2 22.5 0.631
Gurusamy 44 M 120 138 48 65 NIL NIL 13.8 23.1 0.597
Kavitha 47 F 120 70 27 61.4 NIL Trivial 13.7 21.5 0.637
Ramasamy 65 M 110 147 65.9 55.2 Grade 1 NIL 14.7 23.4 0.628
Gajendran 40 M 90 129 58.1 55.1 NIL NIL 13.3 22 0.604
Angalammal 56 F 110 97.3 27 72 NIL NIL 14.4 20.6 0.699
Manimegalai 38 F 90 88 35 60 NIL NIL 13.5 19.7 0.685
Rajamanickam 37 M 110 147 61.9 57.9 NIL NIL 14.6 21.2 0.688
Pavithra 57 F 120 129 50.8 60.7 NIL Trivial 12.8 22.4 0.571
Pachaiyappan 45 M 110 107 35 67.4 NIL NIL 14.8 19.8 0.747
Mahendran 42 M 120 153 58.1 62.1 NIL NIL 13.9 23.4 0.594
Kaliammal 55 F 120 97.3 40.9 57.9 NIL NIL 13.7 19.4 0.706
Divya 37 F 90 112 50.8 55 NIL NIL 13.6 20.7 0.657
Sangaraiyan 65 M 110 141 61.9 56 Grade 1 NIL 14.2 19.4 0.731
Moorthy 60 M 100 107 44.1 58.9 NIL NIL 14.6 20.7 0.705
Thulasi 48 F 100 97.3 40.9 57.9 NIL Trivial 13.4 20.6 0.623
Dinakar 53 M 110 153 58 62 NIL NIL 14.1 21.5 0.655
Poosam 46 F 90 107 44.1 58.9 NIL NIL 13.5 20.3 0.665
Pothumponnu 48 F 100 74.2 32.2 56.6 NIL NIL 13.7 19.3 0.709
Name Age (yrs) Sex PPI Indicn Years since PPI QRS durn (ms) LV EDV (ml) LV ESV (ml) LV EF (%) LV DD MR severity MAPSE (mm) TAPSE (mm) MAPSE/TAPSE ratio
Kala 31 F CHB 1 150 87.6 35 60 NIL NIL 13.3 20.6 0.645
Krishnamoorthy 33 M CHB 1 150 141 61.9 56.1 NIL NIL 13.4 22.2 0.603
Murugan 33 M CHB 1 155 107 35 67.4 NIL NIL 14.4 23.6 0.61
Pandian 33 M SSS 1 160 107 44.1 58.9 NIL NIL 15.2 23.5 0.648
Vijaya 34 F CHB 2 155 70 27 61.4 NIL NIL 14.2 23.6 0.601
Kulanthai Therasa 34 F CHB 1 155 97.3 40.9 57.9 NIL NIL 12.6 21.3 0.591
Murugesan 37 M CHB 1 155 129 50.8 45.9 NIL Trivial 14.7 23.9 0.674
Ganesh 38 M SSS 1 165 153 58 62 NIL NIL 14.7 21.9 0.671
Sheikh Kasim Ali 42 M CHB 2 160 153 58.1 62.1 NIL NIL 13.8 22.5 0.61
Lakshmi 44 F CHB 1 160 118 61.9 47.6 NIL Trivial 10.6 15.9 0.666
Kaniammal 44 F SSS 1 160 97.3 40.9 57.9 NIL NIL 13.7 20.9 0.655
Shanmugam 45 M SSS 1 160 153 58.1 62.1 NIL NIL 14.8 21.8 0.678
Adhiyammal 45 F CHB 1 180 166 112 32.2 Grade 1 Mild 9.6 15.1 0.635
Indira Gandhi 46 F CHB 1 150 107 44.1 58.9 NIL NIL 12.7 22.7 0.559
Jayaraman 48 M SSS 2 150 141 54.4 57.9 NIL NIL 14.1 21.6 0.652
Balu 48 M SSS 2 155 153 65.9 57.1 NIL Trivial 14.8 20.7 0.714
Pandi 48 M CHB 1 165 129 58.1 55.1 NIL NIL 14.8 21.6 0.685
Veerappan 48 M SSS 1 165 147 61.9 57.9 NIL NIL 14.1 21.4 0.658
Chinnappa 48 M CHB 1 175 129 70 45.9 Grade 1 Mild 11.6 18.7 0.62
Pushpa 49 F SSS 1 165 112 50.8 54.9 NIL NIL 13.3 19.3 0.689
Kulasekaran 49 M SSS 2 165 129 50.8 60.7 NIL NIL 14.4 22.8 0.631
Govindaraj 50 M SSS 1 170 141 78 44 NIL Mild 12.2 17.4 0.701
Rajendran 51 M CHB 1 160 147 65.9 55.2 Grade 1 NIL 13.4 22.7 0.59
Vimala 52 F CHB 2 160 97.3 27 72.2 NIL NIL 14.6 22.1 0.66
Perumal 52 M CHB 1 160 147 65.9 55.2 NIL NIL 14.2 23.4 0.606
Kalirathinam 53 M CHB 1 165 129 58 55 NIL NIL 13.8 22.8 0.605
Krishnaveni 55 F SSS 1 165 102 50.8 54.9 NIL NIL 13.6 21.8 0.623
Muniammal 58 F CHB 1 155 129 50.8 60.7 NIL NIL 13.7 22.5 0.608
Nithya 58 F CHB 1 160 74.2 32.2 56.6 NIL NIL 14.6 21.2 0.688
Shakunthala 58 F CHB 1 165 83 29.5 64.4 NIL NIL 14.5 22 0.659
Masilamani 58 M CHB 2 165 147 61.9 57.9 NIL NIL 14.8 21.9 0.675
Babyammal 60 F CHB 1 155 107 58.1 45.9 NIL NIL 11.3 16.8 0.672
Kanniappan 62 M SSS 1 170 112 54 52 NIL NIL 12.8 18.9 0.677
Kesavan 62 M CHB 1 175 147 87.6 40.5 Grade 1 Moderate 9.4 15.7 0.598
Rajeswari 66 F CHB 1 160 130 70 45.4 NIL NIL 10.3 18.7 0.55
Lakshmi 66 F CHB 1 165 129 65.9 49.1 NIL Trivial 12.9 19.4 0.664
Amirthavalli 66 F CHB 1 185 141 107 23.9 Grade 3 Moderate 9.7 14.6 0.664
Sivalingam 67 M CHB 2 160 129 54.4 57.9 NIL NIL 13.9 21.8 0.637
Thirupathi 68 M CHB 1 180 166 118 29 Grade 3 Severe 9.8 16.8 0.583
Pachaiyappan 75 M CHB 1 170 153 83 45.9 Grade 1 NIL 10.2 16.8 0.607
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